Search company, investor...

Founded Year



Unattributed | Alive

Total Raised


Last Raised

$25M | 1 mo ago

About Neuros Medical

Neuros Medical focuses on the development of proprietary therapies. The company's Altius system treats chronic post-amputation pain (phantom limb pain and residual limb pain). Neuros Medical was founded in 2008 and is based in Aliso Viejo, California.

Headquarters Location

26800 Aliso Viejo Parkway Suite 250

Aliso Viejo, California, 92656,

United States




Expert Collections containing Neuros Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Neuros Medical is included in 1 Expert Collection, including Game Changers 2018.


Game Changers 2018

70 items

Neuros Medical Patents

Neuros Medical has filed 11 patents.

The 3 most popular patent topics include:

  • neurophysiology
  • neurological disorders
  • taar1 agonists
patents chart

Application Date

Grant Date


Related Topics




Carboxylate esters, Hybrid electric cars, Cocaine, Tropanes, Piperidines


Application Date


Grant Date



Related Topics

Carboxylate esters, Hybrid electric cars, Cocaine, Tropanes, Piperidines



Latest Neuros Medical News

Neuros Medical Receives $25 Million From Trinity Capital

Nov 8, 2023

Trinity Capital – a leading provider of diversified financial solutions to growth-stage companies – recently announced the commitment of $25 million in growth capital to Neuros Medical, a bioelectric technology company focused on alleviating chronic post-amputation pain and restoring quality of life. Neuros Medical’s Altius System integrates the company’s patented platform technology, On-Demand Bioelectric Nerve Block – which patients initiate as needed for targeted pain relief. And the technology blocks sensory nerves and has the potential to alleviate pain in nearly one million Americans with phantom limb and residual limb pain, fulfilling a significant need for patients. This system has the potential to reduce drug dependency as existing treatment options are primarily limited to opioids and gabapentinoids. The growth capital is going to enable Neuros Medical to augment the recent equity raised and further scale operations to assist with their commercial launch. KEY QUOTES: “We are proud to partner with Neuros Medical on their journey to improve the lives of those suffering from chronic post-amputation pain, and we look forward to working with their team to support their continued growth.” — Rob Lake, Senior Managing Director, Life Sciences at Trinity “We appreciate the conviction Trinity has in the Neuros mission and our ability to scale commercialization, delivering this life-changing therapy to a large, underserved amputee population in desperate need of pain relief.” — David Veino, President and Chief Executive Officer of Neuros Medical Sponsors

Neuros Medical Frequently Asked Questions (FAQ)

  • When was Neuros Medical founded?

    Neuros Medical was founded in 2008.

  • Where is Neuros Medical's headquarters?

    Neuros Medical's headquarters is located at 26800 Aliso Viejo Parkway, Aliso Viejo.

  • What is Neuros Medical's latest funding round?

    Neuros Medical's latest funding round is Unattributed.

  • How much did Neuros Medical raise?

    Neuros Medical raised a total of $133.85M.

  • Who are the investors of Neuros Medical?

    Investors of Neuros Medical include Trinity Capital Investment, Osage University Partners, U.S. Venture Partners, Aperture Venture Partners, Prism VentureWorks and 22 more.

  • Who are Neuros Medical's competitors?

    Competitors of Neuros Medical include Synapse Biomedical, Vapotherm, AirXpanders, Beta-O2 Technologies, FluimediX and 7 more.


Compare Neuros Medical to Competitors


CardioVention develops cardiopulmonary bypass systems

Synapse Biomedical Logo
Synapse Biomedical

Synapse Biomedical is a company focused on the research, development, and commercialization of neurostimulation products in the healthcare sector. The company's main offering is a diaphragm pacing system, a technology designed to decrease the reliance on mechanical ventilators for patients with spinal cord injuries and other conditions causing chronic respiratory insufficiency. Synapse Biomedical primarily serves the healthcare industry, with a particular focus on patients with spinal cord injuries and ALS. It was founded in 2002 and is based in Oberlin, Ohio.

Ark Sciences

Ark Sciences LLC develops pharmaceutical products for animals and their pharmaceutical products are specifically engineered to provide the least invasive, non-surgical sterilization processes possible. Rather than castrating dogs, which can be painful and lead to possibly harmful side-effects, with Ark Sciences' patent protected products, veterinarians and animal welfare specialists have a safe, reliable and cost-effective sterilization treatment.

CIVCO Medical Solutions

CIVCO Medical Solutions is a manufacturer of ultrasound guidance devices and infection control products. CIVCO Medical Solutions is committed to positively impacting patient care by constantly innovating life enhancing medical solutions.

SONIC innovations Logo
SONIC innovations

SONIC Innovations offers digital hearing aids

Rheonix Logo

Rheonix is a company focused on improving standards of care by making molecular diagnostics more accessible, operating in the healthcare and biotechnology sectors. The company offers a highly customizable technology platform, the Encompass platform, which performs fully automated, complex molecular assays in an easy-to-use and economical format. Rheonix primarily serves the healthcare industry, with a particular focus on molecular diagnostic market sectors. It is based in Ithaca, New York.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.